Hepatic clinical trials

Explore recruiting hepatic clinical trials.

Recruiting hepatic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study About Fazirsiran in People With and Without Liver Problems.

Hungary, Slovakia

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Study to Assess the Pharmacokinetics of Rifaximin Soluble Solid Dispersion (SSD) Formulation in Adult Subjects with Impaired Hepatic Function

Hungary

Human Pharmacology (Phase I)- Other EU CTIS Study details

PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy for initially unresectable colorectal liver metastases: a randomised controlled trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Preventing liver recurrence after partial hepatectomy for intrahepatic cholangiocarcinoma using adjuvant hepatic arterial infusion pump chemotherapy – PUMP IV trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR/Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

"Imaging with 68Ga-DOTA-peptides and peptide receptor radionuclide therapy with 177Lu-DOTA-peptides of gastroenteropancreatic neuroendocrine tumors: interest of intra-arterial hepatic infusion in patients with dominant liver metastases" "LUTARTERIAL"

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Hepatic trials by city

Hepatic in Toronto Hepatic in Vancouver Hepatic in Montreal Hepatic in Calgary Hepatic in Edmonton Hepatic in Ottawa Hepatic in Winnipeg Hepatic in Quebec City Hepatic in Hamilton Hepatic in Kitchener Hepatic in London Hepatic in Halifax Hepatic in New York Hepatic in Los Angeles Hepatic in Chicago Hepatic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease